loader
Please Wait
Applying Filters...

Seqens Seqens

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    List of All Manufacturers & Suppliers for 211994 Licensing, EU CTD Dossiers, Marketing Authorizations, Finished Dosage Formulations listed on PharmaCompass.com

    Client Virtual Booth
    Menu

    ViiV Healthcare

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    DEVELOPMENTS

    DOSSIERs // Finished Dosage Forms

    PharmaCompass

    Minakem offers CDMO services for API & HPAPI, generics, regulatory expertise, track record performance & FDA & GMP certifications.

    Send me more info on How To Grow My Business Digitally?

    Left Arrow
    Right Arrow
    Filters Filter
    Cross PopUp
    FILTER :

    filter

    01 DOLUTEGRAVIR SODIUM; LAMIVUDINE (1)

    filter

    01 VIIV HLTHCARE (1)

    filter

    01 TABLET;ORAL (1)

    filter

    01 EQ 50MG BASE;300MG (1)

    filter

    01 USA (1)

    ListList of Suppliers
    refresh Reset Filter
    refresh Reset Filter
    product-page Supplier Virtual Booth
    price-trend Ask Us
    Contact Supplier
      Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
      Post an Enquiry Post an Enquiry
      Flag United Kingdom
      Virtual Booth Virtual Booth
      Digital Content Digital Content

      Dolutegravir Sodium; Lamivudine

      PDF Supplier PDF
      URL Supplier Web Content
      TABLET;ORAL
      EQ 50MG BASE;300MG
      DOVATO
      USA
      211994
      2019-04-08
      RX
      ASK
      US
      PHARMACOMPASS
      Upload
      your Marketing & Sales content

      Looking for CTD TGA MCC DOSSIER APPLICATION 211994

      Looking for CTD TGA MCC DOSSIER APPLICATION 211994 1

      19

      ViiV Healthcare, based in United Kingdom, is a pharmaceutical company.

      One of their notable products is DOLUTEGRAVIR SODIUM; LAMIVUDINE, with a corresponding application number 211994 and regulatory information .

      proudly manufactured in the

      approval since 2019-04-08

      ViiV Healthcare's DOVATO TABLET;ORAL, medication with EQ 50MG BASE;300MG of DOLUTEGRAVIR SODIUM; LAMIVUDINE.

      Post Enquiry
      POST ENQUIRY